WO2007101664A3 - Verbesserter aspergillosetest in klinischen proben - Google Patents

Verbesserter aspergillosetest in klinischen proben Download PDF

Info

Publication number
WO2007101664A3
WO2007101664A3 PCT/EP2007/001939 EP2007001939W WO2007101664A3 WO 2007101664 A3 WO2007101664 A3 WO 2007101664A3 EP 2007001939 W EP2007001939 W EP 2007001939W WO 2007101664 A3 WO2007101664 A3 WO 2007101664A3
Authority
WO
WIPO (PCT)
Prior art keywords
aspergillosis
test
improved
clinical samples
methods
Prior art date
Application number
PCT/EP2007/001939
Other languages
English (en)
French (fr)
Other versions
WO2007101664A2 (de
Inventor
Juergen Loeffler
Original Assignee
Fungus Bioscience Gmbh
Juergen Loeffler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fungus Bioscience Gmbh, Juergen Loeffler filed Critical Fungus Bioscience Gmbh
Publication of WO2007101664A2 publication Critical patent/WO2007101664A2/de
Publication of WO2007101664A3 publication Critical patent/WO2007101664A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft molekularbiologische Verfahren und Mittel zur Diagnose von Pilzinfektionen, besonders Verfahren zur Extraktion von Pilz-DNA aus einer Probe des tierischen oder menschlichen Körpers und Verfahren und Mittel zum Nachweis einer Aspergillus-Infektion des menschlichen oder tierischen Körpers.
PCT/EP2007/001939 2006-03-08 2007-03-07 Verbesserter aspergillosetest in klinischen proben WO2007101664A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006010693.8 2006-03-08
DE102006010693 2006-03-08

Publications (2)

Publication Number Publication Date
WO2007101664A2 WO2007101664A2 (de) 2007-09-13
WO2007101664A3 true WO2007101664A3 (de) 2007-11-15

Family

ID=38156684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/001939 WO2007101664A2 (de) 2006-03-08 2007-03-07 Verbesserter aspergillosetest in klinischen proben

Country Status (1)

Country Link
WO (1) WO2007101664A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102105584B (zh) 2008-05-28 2014-05-14 花王株式会社 耐热菌类的检测方法
CZ302670B6 (cs) * 2009-04-21 2011-08-24 Masarykova Univerzita Zpusob diagnostiky invazivní aspergilózy a oligonukleotidy pro použití pri tomto zpusobu
CN104450937A (zh) * 2014-12-25 2015-03-25 天津宝瑞生物技术有限公司 检测致病曲霉菌的荧光定量pcr引物、探针及试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073499A2 (en) * 1999-05-28 2000-12-07 Innogenetics N.V. Nucleic acid probes and methods for detecting clinically important fungal pathogens
WO2001055159A1 (de) * 2000-01-28 2001-08-02 Eberhard-Karls-Universität Tübingen Universitätsklinikum Verfahren, kit und dna-sonden zum nachweis einer pilz-spezies in klinischem material
WO2003097815A2 (en) * 2002-05-17 2003-11-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Molecular identification of aspergillus species

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073499A2 (en) * 1999-05-28 2000-12-07 Innogenetics N.V. Nucleic acid probes and methods for detecting clinically important fungal pathogens
WO2001055159A1 (de) * 2000-01-28 2001-08-02 Eberhard-Karls-Universität Tübingen Universitätsklinikum Verfahren, kit und dna-sonden zum nachweis einer pilz-spezies in klinischem material
WO2003097815A2 (en) * 2002-05-17 2003-11-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Molecular identification of aspergillus species

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "High Pure PCR Template Preparation Kit", ROCHE APPLIED SCIENCE, April 2005 (2005-04-01), XP002439230, Retrieved from the Internet <URL:http://web.archive.org/web/20051025172652/http://www.roche-applied-science.com/pack-insert/1796828a.pdf> [retrieved on 20070725] *
BARON O ET AL: "Nucleotide sequencing for diagnosis of sinusal infection by Schizophyllum commune, an uncommon pathogenic fungus.", JOURNAL OF CLINICAL MICROBIOLOGY AUG 2006, vol. 44, no. 8, August 2006 (2006-08-01), pages 3042 - 3043, XP002439229, ISSN: 0095-1137 *
LOEFFLER J ET AL: "Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system.", JOURNAL OF CLINICAL MICROBIOLOGY JUN 2002, vol. 40, no. 6, June 2002 (2002-06-01), pages 2240 - 2243, XP002439228, ISSN: 0095-1137 *

Also Published As

Publication number Publication date
WO2007101664A2 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
WO2007112332A3 (en) Microfluidic chamber assembly for mastitis assay
WO2008021290A8 (en) Organ-specific proteins and methods of their use
WO2010015607A3 (en) Method of evaluating oral cancer risk in human
WO2008051285A3 (en) Methods and compositions for detecting fungi and mycotoxins
WO2009021131A3 (en) System and method for biological sample collection and analyte detection
WO2007039319A3 (en) Dna microarray for rapid identification of candida albicans in blood cultures
EP2020445A4 (de) Nachweis einer entzündungskrankheit und zusammensetzung zur vorbeugung oder behandlung einer entzündungskrankheit
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
WO2006086561A3 (en) Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
EP3236264A3 (de) Proteinnachweis über nanoreporter
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2011006911A3 (en) Mass spectrometric diagnosis of septicemia
EP2634573A3 (de) Kartuschenvorrichtung für ein Messsystem zur Messung der viskoelastischen Eigenschaften einer Probenflüssigkeit, zugehöriges Messsystem und zugehöriges Verfahren
WO2011064225A8 (en) Novel diagnostic method for the diagnosis of alzheimer&#39;s disease or mild cognitive impairment
WO2010065781A3 (en) Lateral flow strip assay with immobilized conjugate
EP2287618A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
WO2006084299A8 (en) Method for evaluating the allergen sensitivity of an individual
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2010033597A3 (en) Methods for detecting overexpression of sparc and therapeutic and diagnostic methods relating to same
WO2013156806A3 (en) Quantitative determination of biomarkers in the erythrocyte cell membrane
WO2007069240A3 (en) Compositions and articles for detection of analytes exceeding a pre-set threshold
ATE474228T1 (de) Reagenz für hämoglobinabbau
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
WO2007042827A3 (en) Treatment and diagnosis of obligate intracellular pathogens
EP2081029A3 (de) Biomarker zur Diagnose diabetischer Retinopathie

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: FESTSTELLUNG EINES RECHTSVERLUSTS NACH REGEL 112(1) EPUE (EPA FORM 1205A VOM 18.11.2008)

122 Ep: pct application non-entry in european phase

Ref document number: 07711813

Country of ref document: EP

Kind code of ref document: A2